Join ASBD now to receive your copy of The Breast

ASBD Meetings

2001 SCIENTIFIC PROGRAM
THURSDAY 20 SEPTEMBER
1600 - 2000	Registration
1830 - 1930	Welcoming Drinks - Sponsored by AstraZeneca
FRIDAY 21 SEPTEMBER
0800 - 1000	Registration
1000 - 1100	Session 1 - Opening Session - Sponsored by AstraZeneca Chair: Colin Furnival Opening Remarks: Welcome Mary Rickard Keynote Address: Advances in surgery Lars Holmberg Keynote Address: Advances in medical oncology Nancy Davidson
1100 - 1130	Morning Break - Sponsored by Aventis Pharma
1130 - 1300	Session 2 - Genetics Chair: Gerda Evans Breast cancer genetics Judith Kirk Clinico-pathologic characteristics and clinical management of women with BRCA1 and BRCA2 associated breast cancer Michael Friedlander Counselling in hereditary breast cancer Kathy Tucker Discussion Faculty
1300 - 1400	Lunch
1400 - 1530	Session 3 - Management of the Axilla Chair: William McLeay Results of the Swedish trial in sentinel node biopsy Lars Holmberg Update on the SNAC Trial Neil Wetzig Will sentinel node biopsy end the debate about routine axillary clearance? - 'no' case Andrew Spillane, 'yes' case Boon Chua Discussion Faculty
1530 - 1600	Afternoon Break - Sponsored by Johnson & Johnson Medical
1600 - 1730	Session 4 - Applied Chemotherapy - Sponsored by Novartis Pharmaceuticals Chair: Michael Green Treatment of metastatic disease Nancy Davidson Significance of HER-2-neu David Grimes NHMRC Clinical Practice Guidelines for the treatment of advanced breast cancer Frances Boyle Discussion Faculty
SATURDAY 22 SEPTEMBER
0700 - 0830	Annual General Meeting
0900 - 1030	Session 5 - Research Issues Chair: Cherrell Hirst Role of ovarian ablation Nancy Davidson Improving cancer diagnosis: Detection of preneoplasia in brea st epithelial cells Julian Barden Targeting molecular mechanisms in cancer Rosemary Balleine Discussion Faculty
1030 - 1100	Morning Break - Sponsored by Schering-Plough
1100 - 1230	Session 6 - Tumour Risk Management Chair: Michael Bilous Risk of invasive cancer after DCIS and LCIS Lars Holmberg Molecular biology and the selection of hormonal treatment Stephen Birrell The St Gallen classification for patients with node-negative breast cancer - Does it really work? John Boyages Discussion Faculty
1230-1330	Lunch
1330 - 1500	Session 7 - The Place of Mastectomy Chair: Margaret Pooley Incidence of local recurrence after complete local excision (CLE) Lars Holmberg Current practice in Australia: RACS Breast Audit data Peter Malycha Advances in breast reconstruction Rod Cooter The role of post-mastectomy radiotherapy Michael Izard Discussion Faculty
1500 - 1530	Afternoon Break - Sponsored by Pharmacia Australia
1530 - 1700	Session 8 - Current Controversies Sponsored by National Breast Cancer Centre Chair: Jack Jellins Current issues in mammography screening Mary Rickard Pathology diagnosis Michael Bilous Late breast cancer presentation Anne Kricker Hormonal replacement therapy after breast cancer - is it safe? (HABITS) Lars Holmberg Oncology Nancy Davidson Closing remarks Jack Jellins
1830 - 2300	Meeting Dinner - Sponsored by AstraZeneca

Ninth Scientific Meeting of ASBD

12-14 September 2013
Cairns Convention Centre, QLD

Website designed by Garnish Garden